Free Trial

Ocean Biomedical (OCEAW) Competitors

$0.03 +0.00 (+7.02%)
(As of 10:35 AM ET)

OCEAW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Ocean Biomedical vs.

180 Life Sciences (NASDAQ:ATNFW) and Ocean Biomedical (NASDAQ:OCEAW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

In the previous week, 180 Life Sciences had 2 more articles in the media than Ocean Biomedical. MarketBeat recorded 3 mentions for 180 Life Sciences and 1 mentions for Ocean Biomedical. 180 Life Sciences' average media sentiment score of 1.87 beat Ocean Biomedical's score of 1.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Very Positive
Ocean Biomedical Positive

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Ocean Biomedical N/A N/A N/A

180 Life Sciences and Ocean Biomedical both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Ocean BiomedicalN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats Ocean Biomedical on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

MetricOcean BiomedicalBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$172.71M$5.21B$9.09B
Dividend YieldN/A3.64%5.11%4.27%
P/E RatioN/A113.7687.2417.17
Price / SalesN/A18,745.981,117.68122.22
Price / CashN/A13.0143.2337.88
Price / BookN/A8.604.844.99
Net IncomeN/A-$20.89M$120.15M$225.13M
7 Day PerformanceN/A0.43%2.44%3.96%
1 Month PerformanceN/A227.97%17.49%2.87%
1 Year PerformanceN/A144.00%27.93%17.05%

Ocean Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/A$0.03
+7.0%
N/A+41.7%$0.00N/A0.002Short Interest ↓
Positive News
ATNFW
180 Life Sciences
N/A$0.01
+6.7%
N/A+96.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.04
-6.8%
N/A+42.2%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.05
-2.7%
N/A-83.9%$0.00$40,633.000.0040Positive News
ALVOW
Alvotech
N/A$2.95
+5.0%
N/A+37.7%$0.00$391.87M0.004Short Interest ↓
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.10
+106.3%
N/A+497.0%$0.00N/A0.004High Trading Volume
BFRIW
Biofrontera
N/A$0.12
+33.3%
N/A+325.5%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
-2.2%
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.27
-4.5%
N/A-83.8%$0.00N/A0.008Short Interest ↓
Gap Up
CELUW
Celularity
N/A$0.02
-5.0%
N/A-67.1%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:OCEAW) was last updated on 12/27/2024 by MarketBeat.com Staff
From Our Partners